Clinical Trials Logo

Clinical Trial Summary

There are two phases. Phase I: A single visit which includes a screening, clinical scales, and a MRI scan with simultaneous tES/sham tES in a randomized block design. Enrolls both Cervical Dystonia (CD) patients and healthy controls. Phase II: 5 consecutive days of 30-90 min visits to campus for tES or sham tES. Transcranial magnetic stimulation (TMS) measures and clinical scales will also be included on Day 1 and Day 5 visits. Enrolls only CD patients.


Clinical Trial Description

Phase I: Enrolls both CD patients and healthy controls. One approximately 3 hour visit which includes: - a screening & neurological exam, - clinical scales & questionnaires, - a (approx.) 60 min MRI scan with simultaneous tES/sham tES in a randomized block design and EMG Phase II: Enrolls only CD patients. Five consecutive days of study visits. Day 1: - TMS screening, - repeated neurological assessment and clinical scales if >1 month since MRI visit - 30 min TMS session with concurrent EMG - 20 min tES or sham tES session Days 2-4: - 20 min tES or sham tES session Day 5: - 20 min tES or sham tES session - 30 min TMS session with concurrent EMG - repeated neurological assessment and clinical scales ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03369613
Study type Interventional
Source University of Colorado, Denver
Contact
Status Completed
Phase N/A
Start date October 27, 2017
Completion date September 20, 2021

See also
  Status Clinical Trial Phase
Completed NCT02542839 - rTMS and Botulinum Toxin in Primary Cervical Dystonia N/A
Completed NCT02046447 - Neuroimaging of Dystonia N/A